Navigation Links
Early childhood diet may influence future health
Date:1/14/2009

If you have trouble keeping weight off and you're wondering why the surprising answer may well be the cheeseburgers you ate when you were a toddler.

Surprising new research by University of Calgary, Faculty of Kinesiology researcher Dr. Raylene Reimer, published in an international journal, indicates a direct connection between an adult's propensity to put on weight and our early childhood diet.

Reimer is a leader in a growing field of study that examines the developmental origins of health and disease. Researchers in this area believe our pre-natal and early childhood environment influences our future risk of developing conditions like cardio vascular disease, obesity and diabetes.

"My research has shown that the food we eat changes how active certain genes in our body are what we call genetic expression. In particular we believe that our diet has a direct influence on the genes that control how our bodies store and use nutrients," says Reimer. "There's a growing body of work that indicates a relationship between our health as adults and our early diet, and even our mother's diet. This research shows for the first time that our early childhood diet may have a huge impact on our health as adults."

Reimer's study published in the current Journal of Physiology (London,) compares three groups of rats. At a very young age the rats were weaned onto three separate diets. One group was fed a high protein diet; one group was fed a high fibre diet and a third group was fed a control diet. When the rats became adults, they were switched to a high fat, high sugar diet, which reflects the reality of the typical western diet.

The results were astonishing. The group of rats who were reared on the high protein diet as packed on much more weight and body fat than the rats who had 'grown up' eating the high-fibre diet, who put on the least amount of weight and body fat.

"I believe this study clearly shows that the
'/>"/>

Contact: Don McSwiney
don.mcswiney@ucalgary.ca
403-220-7652
University of Calgary
Source:Eurekalert

Page: 1 2

Related biology news :

1. 60 second test could help early diagnosis of common brain diseases
2. Restless legs syndrome affects nearly 2 percent of US/UK children
3. Bleeding, not inflammation, is major cause of early lung infection death
4. Pig study sheds new light on the colonisation of Europe by early farmers
5. Color contrast is seen by the brain early doors
6. Extra gene copies were enough to make early humans mouths water
7. Was ability to run early mans Achilles heel?
8. New technique can be breakthrough for early cancer diagnosis
9. Yam bean a nearly forgotten crop
10. NIH awards nearly $23M to University of Chicago for translational research
11. Yam bean a nearly forgotten crop
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):Stem cells battle for space 2Lower income women report more insurance-based discrimination during pregnancy, delivery 2Scientists think 'killer petunias' should join the ranks of carnivorous plants 2Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA 28TM 29 in Systemic Lupus Erythematosus 4741 1Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA 28TM 29 in Systemic Lupus Erythematosus 4741 2Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA 28TM 29 in Systemic Lupus Erythematosus 4741 3Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA 28TM 29 in Systemic Lupus Erythematosus 4741 4Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA 28TM 29 in Systemic Lupus Erythematosus 4741 5Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA 28TM 29 in Systemic Lupus Erythematosus 4741 6Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA 28TM 29 in Systemic Lupus Erythematosus 4741 7Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA 28TM 29 in Systemic Lupus Erythematosus 4741 8Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA 28TM 29 in Systemic Lupus Erythematosus 4741 9Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA 28TM 29 in Systemic Lupus Erythematosus 4741 10Depression Poses Pregnancy Risks 52055 1Depression Poses Pregnancy Risks 52055 2Depression Poses Pregnancy Risks 52055 3The Biggest Loser Confirms Talent6 as a Reality TV Heavyweight 52052 1The Biggest Loser Confirms Talent6 as a Reality TV Heavyweight 52052 2The Biggest Loser Confirms Talent6 as a Reality TV Heavyweight 52052 3
Breaking Biology Technology:Peregrine Pharmaceuticals to Report Second Quarter FY 2010 Financial Results 2Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4